Valuation: Rani Therapeutics Holdings, Inc.

Market Cap 6.78Cr 6.06Cr 5.6Cr 5.07Cr 9.49Cr 643.85Cr 9.64Cr 67Cr 27Cr 337.33Cr 25Cr 25Cr 1.06TCr P/E 2026 *
-3.39x
P/E 2027 * -3.09x
Enterprise Value 6.78Cr 6.06Cr 5.6Cr 5.07Cr 9.49Cr 643.85Cr 9.64Cr 67Cr 27Cr 337.33Cr 25Cr 25Cr 1.06TCr EV / Sales 2026 *
10.8x
EV / Sales 2027 * 10.2x
Free-Float
4.26%
Yield 2026 *
-
Yield 2027 * -
1 day+3.30%
1 week-5.09%
Current month-23.14%
1 month-20.73%
3 months-31.69%
6 months-33.59%
Current year-54.96%
1 week 0.57
Extreme 0.5737
0.68
1 month 0.57
Extreme 0.5737
0.85
Current year 0.57
Extreme 0.5737
1.54
1 year 0.57
Extreme 0.5737
2.63
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Chairman 69 01/06/2021
Director/Board Member 80 01/09/2018
Director/Board Member 69 06/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
27/09/26 Tax

Chief Executive Officer

-7,928 0.0080%
27/09/26 Tax

Chief Technology Officer

-309 0.0003%
03/08/26 Free

Director

2,47,200 0.2479%
Change 5-day change 1-year change 3-year change Capi.($)
+3.30%-5.09%-70.91%-68.98% 6.78Cr
+2.41%-6.33%+43.43%+71.02% 6.33TCr
-0.15%+7.50%+11.01%+73.48% 5.49TCr
+0.57%+4.60%+10.07%+92.86% 5.33TCr
+0.40%+4.47%+26.80%+51.78% 4.58TCr
-1.25%+2.15%+21.60%+123.44% 4.35TCr
+0.04%+5.36%+250.84%+921.47% 4.02TCr
+0.05%+6.75%+14.48%+56.75% 3.35TCr
+1.19%-5.84%+27.86%-0.65% 2.37TCr
-0.38%+5.68%+36.43%+27.54% 2.38TCr
Average +0.62%-1.06%+37.16%+134.87% 3.82TCr
Weighted average by Cap. +0.42%+0.55%+47.53%+159.22%

Financials

2026 *2027 *
Net sales 62.58L 55.88L 51.62L 46.78L 87.52L 59Cr 88.97L 6.21Cr 2.46Cr 31Cr 2.35Cr 2.3Cr 98Cr 66.32L 59.23L 54.72L 49.58L 92.77L 63Cr 94.3L 6.58Cr 2.61Cr 33Cr 2.49Cr 2.44Cr 104Cr
Net income -3.15Cr -2.81Cr -2.6Cr -2.35Cr -4.4Cr -298.65Cr -4.47Cr -31Cr -12Cr -156.47Cr -12Cr -12Cr -493.32Cr -3.67Cr -3.28Cr -3.03Cr -2.75Cr -5.14Cr -348.65Cr -5.22Cr -36Cr -14Cr -182.67Cr -14Cr -13Cr -575.9Cr
Net Debt - -
Projected Income Statement - Annual - Rani Therapeutics Holdings, Inc.
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
24/26/24 $0.6080 +3.47% 2,63,273
22/26/22 $0.5876 -2.88% 7,73,552
21/26/21 $0.6050 -7.32% 6,88,340
20/26/20 $0.6528 +0.38% 4,59,300
19/26/19 $0.6503 +1.51% 4,57,869
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Rani Therapeutics Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5876USD
Average target price
7.200USD
Spread / Average Target
+1,125.32%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Rani Therapeutics Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. RANI Stock